fips |
Char |
5 |
$5. |
$5. |
5Digit Fips State-County Code, Character |
stabr |
Char |
2 |
$2. |
$2. |
State Name Abbreviation |
year |
Num |
8 |
BEST8. |
BEST8. |
Year |
msac |
Char |
4 |
|
|
4Digit MSA/PMSA Code, Character |
cntyst |
Char |
30 |
$30. |
$30. |
County Name W/State Abbrev |
cenregn |
Char |
13 |
|
|
Census Region Name |
cenregc |
Num |
8 |
|
|
Census Region Code |
cendivn |
Char |
18 |
|
|
Census Division Name |
cendivc |
Num |
8 |
|
|
Census Division Code |
msapmsa99c |
Num |
8 |
|
|
MSA/PMSA Code 1999 |
poptot |
Num |
8 |
|
|
Total Population in 1000s |
kids0t4 |
Num |
8 |
|
|
Children (Age 0 to 4) |
kids5t19 |
Num |
8 |
|
|
Children (Age 5 to 19) |
kids |
Num |
8 |
|
|
Children Aged 5-19 |
pcpi |
Num |
8 |
|
|
Per Capita Personal Income (Real 2000 $s)/1000) |
mds |
Num |
8 |
|
|
Total MDs in 1000s (MDTPC) |
caiddrugs |
Num |
8 |
|
|
Amount Reimbured for Drugs by Medicaid |
mcaidenrollees |
Num |
8 |
|
|
Medicaid Enrollees in State (Census Estimates) |
lncaiddrugs |
Num |
8 |
|
|
Log (Total Amount Reimbured for Drugs by Medicaid) |
lnmcaidenrollees |
Num |
8 |
|
|
Log(Medicaid Enrollees in State (Census Estimates)) |
lnpop |
Num |
8 |
|
|
|
lnkids |
Num |
8 |
|
|
|
lnmds |
Num |
8 |
|
|
|
t1 |
Num |
8 |
|
|
Time (t1): 1 is year 1999 |
t2 |
Num |
8 |
|
|
Time Sq (t2): 1 is year 1999 |
rr |
Num |
8 |
|
|
Total Revenue (All Drugs) |
y1 |
Num |
8 |
|
|
y1: Total Revenue in MPH-IR |
y2 |
Num |
8 |
|
|
y2: Total Revenue in MPH-ER |
y3 |
Num |
8 |
|
|
y3: Total Revenue in MPH-OROS |
y4 |
Num |
8 |
|
|
y4: Total Revenue in MAS-IR |
y5 |
Num |
8 |
|
|
y5: Total Revenue in MAS-ER |
y6 |
Num |
8 |
|
|
y6: Total Revenue in DEX-IR |
y7 |
Num |
8 |
|
|
y7: Total Revenue in DEX-ER |
y8 |
Num |
8 |
|
|
y8: Total Revenue in OTH |
yy1 |
Num |
8 |
|
|
yy1: Total Revenue in MPH |
yy2 |
Num |
8 |
|
|
yy2: Total Revenue in MAS |
yy3 |
Num |
8 |
|
|
yy3: Total Revenue in DEX |
yy4 |
Num |
8 |
|
|
yy4: Total Revenue in OTH |
r1 |
Num |
8 |
|
|
r1: Sales of Ritalin (real 2000 $s) |
r2 |
Num |
8 |
|
|
r2: Sales of Methylin (real 2000 $s) |
r3 |
Num |
8 |
|
|
r3: Sales of Generic MPH-IR (real 2000 $s) |
r4 |
Num |
8 |
|
|
r4 : Sales of Ritalin SR/LA (real 2000 $s) |
r5 |
Num |
8 |
|
|
r5 : Sales of Metadate CD/ER (real 2000 $s) |
r6 |
Num |
8 |
|
|
r6 : Sales of Methylin ER (real 2000 $s) |
r7 |
Num |
8 |
|
|
r7 : Sales of Generic MPH-ER (real 2000 $s) |
r8 |
Num |
8 |
|
|
r8 : Sales of Concerta (real 2000 $s) |
r9 |
Num |
8 |
|
|
r9 : Sales of Adderall (real 2000 $s) |
r10 |
Num |
8 |
|
|
r10 : Sales of Generic MAS-IR (real 2000 $s) |
r11 |
Num |
8 |
|
|
r11 : Sales of Adderall XR (real 2000 $s) |
r12 |
Num |
8 |
|
|
r12 : Sales of Dexedrine (real 2000 $s) |
r13 |
Num |
8 |
|
|
r13 : Sales of Dextrostat (real 2000 $s) |
r14 |
Num |
8 |
|
|
r14 : Sales of Generic DEX-IR (real 2000 $s) |
r15 |
Num |
8 |
|
|
r15 : Sales of Dexedrine SR (real 2000 $s) |
r16 |
Num |
8 |
|
|
r16 : Sales of Generic DEX-ER (real 2000 $s) |
r17 |
Num |
8 |
|
|
r17: Sales of 17a,17b,17c,17d (real 2000 $s) |
qq |
Num |
8 |
|
|
Total Quantity (All Drugs) |
q1 |
Num |
8 |
|
|
q1: Qnty of Ritalin |
q2 |
Num |
8 |
|
|
q2: Qnty of Methylin |
q3 |
Num |
8 |
|
|
q3: Qnty of Generic MPH-IR |
q4 |
Num |
8 |
|
|
q4: Qnty of Ritalin SR/LA |
q5 |
Num |
8 |
|
|
q5: Qnty of Metadate CD/ER |
q6 |
Num |
8 |
|
|
q6: Qnty of Methylin ER |
q7 |
Num |
8 |
|
|
q7: Qnty of Generic MPH-ER |
q8 |
Num |
8 |
|
|
q8: Qnty of Concerta |
q9 |
Num |
8 |
|
|
q9: Qnty of Adderall |
q10 |
Num |
8 |
|
|
q10: Qnty of Generic MAS-IR |
q11 |
Num |
8 |
|
|
q11: Qnty of Adderall XR |
q12 |
Num |
8 |
|
|
q12: Qnty of Dexedrine |
q13 |
Num |
8 |
|
|
q13: Qnty of Dextrostat |
q14 |
Num |
8 |
|
|
q14: Qnty of Generic DEX-IR |
q15 |
Num |
8 |
|
|
q15: Qnty of Dexedrine SR |
q16 |
Num |
8 |
|
|
q16: Qnty of Generic DEX-ER |
q17 |
Num |
8 |
|
|
q17: Qnty of 17a,17b,17c,17d |
po1 |
Num |
8 |
|
|
po1: Price of Ritalin |
po2 |
Num |
8 |
|
|
po2: Price of Methylin |
po3 |
Num |
8 |
|
|
po3: Price of Generic MPH-IR |
po4 |
Num |
8 |
|
|
po4: Price of Ritalin SR/LA weighted by shares of revenues |
po5 |
Num |
8 |
|
|
po5: Price of Metadate CD/ER weighted by shares of revenues |
po6 |
Num |
8 |
|
|
po6: Price of Methylin ER |
po7 |
Num |
8 |
|
|
po7: Price of Generic MPH-ER |
po8 |
Num |
8 |
|
|
po8: Price of Concerta |
po9 |
Num |
8 |
|
|
po9: Price of Adderall |
po10 |
Num |
8 |
|
|
po10: Price of Generic MAS-IR |
po11 |
Num |
8 |
|
|
po11: Price of Adderall XR |
po12 |
Num |
8 |
|
|
po12: Price of Dexedrine |
po13 |
Num |
8 |
|
|
po13: Price of Dextrostat |
po14 |
Num |
8 |
|
|
po14: Price of Generic DEX-IR |
po15 |
Num |
8 |
|
|
po15: Price of Dexedrine SR |
po16 |
Num |
8 |
|
|
po16: Price of Generic DEX-ER |
po17 |
Num |
8 |
|
|
po17: Price of 17a,17b,17c,17d weighted by shares of revenues |
lpo1 |
Num |
8 |
|
|
lpo1: log Price of Ritalin |
lpo2 |
Num |
8 |
|
|
lpo2: log Price of Methylin |
lpo3 |
Num |
8 |
|
|
lpo3: log Price of Generic MPH-IR |
lpo4 |
Num |
8 |
|
|
lpo4: log Price of Ritalin SR/LA weighted by shares of revenues |
lpo5 |
Num |
8 |
|
|
lpo5: log Price of Metadate CD/ER weighted by shares of revenues |
lpo6 |
Num |
8 |
|
|
lpo6: log Price of Methylin ER |
lpo7 |
Num |
8 |
|
|
lpo7: log Price of Generic MPH-ER |
lpo8 |
Num |
8 |
|
|
lpo8: log Price of Concerta |
lpo9 |
Num |
8 |
|
|
lpo9: log Price of Adderall |
lpo10 |
Num |
8 |
|
|
lpo10: log Price of Generic MAS-IR |
lpo11 |
Num |
8 |
|
|
lpo11: log Price of Adderall XR |
lpo12 |
Num |
8 |
|
|
lpo12: log Price of Dexedrine |
lpo13 |
Num |
8 |
|
|
lpo13: log Price of Dextrostat |
lpo14 |
Num |
8 |
|
|
lpo14: log Price of Generic DEX-IR |
lpo15 |
Num |
8 |
|
|
lpo15: log Price of Dexedrine SR |
lpo16 |
Num |
8 |
|
|
lpo16: log Price of Generic DEX-ER |
lpo17 |
Num |
8 |
|
|
lpo17: log Price of 17a,17b,17c,17d weighted by shares of revenues |
s1 |
Num |
8 |
|
|
s1: Rel Share of Ritalin (in MPH-IR) |
s2 |
Num |
8 |
|
|
s2: Rel Share of Methylin (in MPH-IR) |
s3 |
Num |
8 |
|
|
s3: Rel Share of Generic MPH-IR (in MPH-IR) |
s4 |
Num |
8 |
|
|
s4: Rel Share of Ritalin SR/LA (in MPH-ER) |
s5 |
Num |
8 |
|
|
s5: Rel Share of Metadate CD/ER (in MPH-ER) |
s6 |
Num |
8 |
|
|
s6: Rel Share of Methylin ER (in MPH-ER) |
s7 |
Num |
8 |
|
|
s7: Rel Share of Generic MPH-ER (in MPH-ER) |
s8 |
Num |
8 |
|
|
s8: Rel Share of Concerta (in MPH-OROS) |
s9 |
Num |
8 |
|
|
s9: Rel Share of Adderall (in MAS-IR) |
s10 |
Num |
8 |
|
|
s10: Rel Share of Generic MAS-IR (in MAS-IR) |
s11 |
Num |
8 |
|
|
s11: Rel Share of Adderall XR (in MAS-ER) |
s12 |
Num |
8 |
|
|
s12: Rel Share of Dexedrine (in DEX-IR) |
s13 |
Num |
8 |
|
|
s13: Rel Share of Dextrostat (in DEX-IR) |
s14 |
Num |
8 |
|
|
s14: Rel Share of Generic DEX-IR (in DEX-IR) |
s15 |
Num |
8 |
|
|
s15: Rel Share of Dexedrine SR (in DEX-ER) |
s16 |
Num |
8 |
|
|
s16: Rel Share of Generic DEX-ER (in DEX-ER) |
s17 |
Num |
8 |
|
|
s17: Rel Share of 17a,17b,17c,17d (in OTH) |
u1 |
Num |
8 |
|
|
u1: Rel Share of MPH-IR in MPH |
u2 |
Num |
8 |
|
|
u2: Rel Share of MPH-ER in MPH |
u3 |
Num |
8 |
|
|
u3: Rel Share of MPH-OROS in MPH |
u4 |
Num |
8 |
|
|
u4: Rel Share of MAS-IR in MAS |
u5 |
Num |
8 |
|
|
u5: Rel Share of MAS-ER in MAS |
u6 |
Num |
8 |
|
|
u6: Rel Share of DEX-IR in DEX |
u7 |
Num |
8 |
|
|
u7: Rel Share of DEX-ER in DEX |
u8 |
Num |
8 |
|
|
u8: Rel Share of OTH in OTH |
m1 |
Num |
8 |
|
|
m1: Rel Share of MPH in MOLS |
m2 |
Num |
8 |
|
|
m2: Rel Share of MAS in MOLS |
m3 |
Num |
8 |
|
|
m3: Rel Share of DEX in MOLS |
m4 |
Num |
8 |
|
|
m4: Rel Share of OTH in MOLS |
so1 |
Num |
8 |
|
|
so1: Avg of s1 over fips within year |
so2 |
Num |
8 |
|
|
so2: Avg of s2 over fips within year |
so3 |
Num |
8 |
|
|
so3: Avg of s3 over fips within year |
so4 |
Num |
8 |
|
|
so4: Avg of s4 over fips within year |
so5 |
Num |
8 |
|
|
so5: Avg of s5 over fips within year |
so6 |
Num |
8 |
|
|
so6: Avg of s6 over fips within year |
so7 |
Num |
8 |
|
|
so7: Avg of s7 over fips within year |
so8 |
Num |
8 |
|
|
so8: Avg of s8 over fips within year |
so9 |
Num |
8 |
|
|
so9: Avg of s9 over fips within year |
so10 |
Num |
8 |
|
|
so10: Avg of s10 over fips within year |
so11 |
Num |
8 |
|
|
so11: Avg of s11 over fips within year |
so12 |
Num |
8 |
|
|
so12: Avg of s12 over fips within year |
so13 |
Num |
8 |
|
|
so13: Avg of s13 over fips within year |
so14 |
Num |
8 |
|
|
so14: Avg of s14 over fips within year |
so15 |
Num |
8 |
|
|
so15: Avg of s15 over fips within year |
so16 |
Num |
8 |
|
|
so16: Avg of s16 over fips within year |
so17 |
Num |
8 |
|
|
so17: Avg of s17 over fips within year |
uo1 |
Num |
8 |
|
|
uo1: Avg of u1 over fips within year |
uo2 |
Num |
8 |
|
|
uo2: Avg of u2 over fips within year |
uo3 |
Num |
8 |
|
|
uo3: Avg of u3 over fips within year |
uo4 |
Num |
8 |
|
|
uo4: Avg of u4 over fips within year |
uo5 |
Num |
8 |
|
|
uo5: Avg of u5 over fips within year |
uo6 |
Num |
8 |
|
|
uo6: Avg of u6 over fips within year |
uo7 |
Num |
8 |
|
|
uo7: Avg of u7 over fips within year |
uo8 |
Num |
8 |
|
|
uo8: Avg of u8 over fips within year |
mo1 |
Num |
8 |
|
|
mo1: Avg of m1 over fips within year |
mo2 |
Num |
8 |
|
|
mo2: Avg of m2 over fips within year |
mo3 |
Num |
8 |
|
|
mo3: Avg of m3 over fips within year |
mo4 |
Num |
8 |
|
|
mo4: Avg of m4 over fips within year |
sr1 |
Num |
8 |
|
|
sr1 : Abs Share (of revenue) of Ritalin |
sr2 |
Num |
8 |
|
|
sr2 : Abs Share (of revenue) of Methylin |
sr3 |
Num |
8 |
|
|
sr3 : Abs Share (of revenue) of Generic MPH-IR |
sr4 |
Num |
8 |
|
|
sr4 : Abs Share (of revenue) of Ritalin SR/LA |
sr5 |
Num |
8 |
|
|
sr5 : Abs Share (of revenue) of Metadate CD/ER |
sr6 |
Num |
8 |
|
|
sr6 : Abs Share (of revenue) of Methylin ER |
sr7 |
Num |
8 |
|
|
sr7 : Abs Share (of revenue) of Generic MPH-ER |
sr8 |
Num |
8 |
|
|
sr8 : Abs Share (of revenue) of Concerta |
sr9 |
Num |
8 |
|
|
sr9 : Abs Share (of revenue) of Adderall |
sr10 |
Num |
8 |
|
|
sr10 : Abs Share (of revenue) of Generic MAS-IR |
sr11 |
Num |
8 |
|
|
sr11 : Abs Share (of revenue) of Adderall XR |
sr12 |
Num |
8 |
|
|
sr12 : Abs Share (of revenue) of Dexedrine |
sr13 |
Num |
8 |
|
|
sr13 : Abs Share (of revenue) of Dextrostat |
sr14 |
Num |
8 |
|
|
sr14 : Abs Share (of revenue) of Generic DEX-IR |
sr15 |
Num |
8 |
|
|
sr15 : Abs Share (of revenue) of Dexedrine SR |
sr16 |
Num |
8 |
|
|
sr16 : Abs Share (of revenue) of Generic DEX-ER |
sr17 |
Num |
8 |
|
|
sr17 : Abs Share (of revenue) of 17a,17b,17c,17d |
poz1 |
Num |
8 |
|
|
poz1: Instrument for price of Ritalin |
poz2 |
Num |
8 |
|
|
poz2: Instrument for price of Methylin |
poz3 |
Num |
8 |
|
|
poz3: Instrument for price of Generic MPH-IR |
poz4 |
Num |
8 |
|
|
poz4: Instrument for price of Ritalin SR/LA |
poz5 |
Num |
8 |
|
|
poz5: Instrument for price of Metadate CD/ER |
poz6 |
Num |
8 |
|
|
poz6: Instrument for price of Methylin ER |
poz7 |
Num |
8 |
|
|
poz7: Instrument for price of Generic MPH-ER |
poz8 |
Num |
8 |
|
|
poz8: Instrument for price of Concerta |
poz9 |
Num |
8 |
|
|
poz9: Instrument for price of Adderall |
poz10 |
Num |
8 |
|
|
poz10: Instrument for price of Generic MAS-IR |
poz11 |
Num |
8 |
|
|
poz11: Instrument for price of Adderall XR |
poz12 |
Num |
8 |
|
|
poz12: Instrument for price of Dexedrine |
poz13 |
Num |
8 |
|
|
poz13: Instrument for price of Dextrostat |
poz14 |
Num |
8 |
|
|
poz14: Instrument for price of Generic DEX-IR |
poz15 |
Num |
8 |
|
|
poz15: Instrument for price of Dexedrine SR |
poz16 |
Num |
8 |
|
|
poz16: Instrument for price of Generic DEX-ER |
poz17 |
Num |
8 |
|
|
poz17: Instrument for price of 17(a,b,c,d) |
lpoz1 |
Num |
8 |
|
|
lpoz1: Instrument for (log) price of Ritalin |
lpoz2 |
Num |
8 |
|
|
lpoz2: Instrument for (log) price of Methylin |
lpoz3 |
Num |
8 |
|
|
lpoz3: Instrument for (log) price of Generic MPH-IR |
lpoz4 |
Num |
8 |
|
|
lpoz4: Instrument for (log) price of Ritalin SR/LA |
lpoz5 |
Num |
8 |
|
|
lpoz5: Instrument for (log) price of Metadate CD/ER |
lpoz6 |
Num |
8 |
|
|
lpoz6: Instrument for (log) price of Methylin ER |
lpoz7 |
Num |
8 |
|
|
lpoz7: Instrument for (log) price of Generic MPH-ER |
lpoz8 |
Num |
8 |
|
|
lpoz8: Instrument for (log) price of Concerta |
lpoz9 |
Num |
8 |
|
|
lpoz9: Instrument for (log) price of Adderall |
lpoz10 |
Num |
8 |
|
|
lpoz10: Instrument for (log) price of Generic MAS-IR |
lpoz11 |
Num |
8 |
|
|
lpoz11: Instrument for (log) price of Adderall XR |
lpoz12 |
Num |
8 |
|
|
lpoz12: Instrument for (log) price of Dexedrine |
lpoz13 |
Num |
8 |
|
|
lpoz13: Instrument for (log) price of Dextrostat |
lpoz14 |
Num |
8 |
|
|
lpoz14: Instrument for (log) price of Generic DEX-IR |
lpoz15 |
Num |
8 |
|
|
lpoz15: Instrument for (log) price of Dexedrine SR |
lpoz16 |
Num |
8 |
|
|
lpoz16: Instrument for (log) price of Generic DEX-ER |
lpoz17 |
Num |
8 |
|
|
lpoz17: Instrument for (log) price of 17(a,b,c,d) |
lpoi1 |
Num |
8 |
|
|
lpoi1: wt. avg. lpo1-lpo3 -- wt fixed shares (PI for MPH-IR) |
lpoi2 |
Num |
8 |
|
|
lpoi2: wt. avg. lpo4-lpo7 -- wt fixed shares (PI for MPH-ER) |
lpoi3 |
Num |
8 |
|
|
lpoi3: wt. avg. lpo8-lpo8 -- wt fixed shares (PI for MPH-OROS) |
lpoi4 |
Num |
8 |
|
|
lpoi4: wt. avg. lpo9-lpo10 -- wt fixed shares (PI for MAS-IR) |
lpoi5 |
Num |
8 |
|
|
lpoi5: wt. avg. lpo11-lpo11 -- wt fixed shares (PI for MAS-ER) |
lpoi6 |
Num |
8 |
|
|
lpoi6: wt. avg. lpo12-lpo14 -- wt fixed shares (PI for DEX-IR) |
lpoi7 |
Num |
8 |
|
|
lpoi7: wt. avg. lpo15-lpo16 -- wt fixed shares (PI for DEX-ER) |
lpoi8 |
Num |
8 |
|
|
lpoi8: wt. avg. lpo17(a,b,c,d) -- wt fixed shares (PI for OTH) |
lpomi1 |
Num |
8 |
|
|
lpomi1: wt. avg. lpoi1-lpoi3 -- wt fixed shares (PI for MPH) |
lpomi2 |
Num |
8 |
|
|
lpomi2: wt. avg. lpoi4-lpoi7 -- wt fixed shares (PI for MAS) |
lpomi3 |
Num |
8 |
|
|
lpomi3: wt. avg. lpoi6-lpoi7 -- wt fixed shares (PI for DEX) |
lpomi4 |
Num |
8 |
|
|
lpomi4: wt. avg. lpoi8-lpoi8 -- wt fixed shares (PI for OTH) |
lpoi |
Num |
8 |
|
|
lpoi: wt. avg. lpomii1-lpoii4 -- wt fixed shares (PI for ALL) |
lpoii1 |
Num |
8 |
|
|
lpoii1: wt. avg. lpo1-lpo3 -- wt actual shares (PI for MPH-IR) |
lpoii2 |
Num |
8 |
|
|
lpoii2: wt. avg. lpo4-lpo7 -- wt actual shares (PI for MPH-ER) |
lpoii3 |
Num |
8 |
|
|
lpoii3: wt. avg. lpo8-lpo8 -- wt actual shares (PI for MPH-OROS) |
lpoii4 |
Num |
8 |
|
|
lpoii4: wt. avg. lpo9-lpo10 -- wt actual shares (PI for MAS-IR) |
lpoii5 |
Num |
8 |
|
|
lpoii5: wt. avg. lpo11-lpo11 -- wt actual shares (PI for MAS-ER) |
lpoii6 |
Num |
8 |
|
|
lpoii6: wt. avg. lpo12-lpo14 -- wt actual shares (PI for DEX-IR) |
lpoii7 |
Num |
8 |
|
|
lpoii7: wt. avg. lpo15-lpo16 -- wt actual shares (PI for DEX-ER) |
lpoii8 |
Num |
8 |
|
|
lpoii8: wt. avg. lpo17(a,b,c,d) -- wt actual shares (PI for OTH) |
lpomii1 |
Num |
8 |
|
|
lpomii1: wt. avg. lpoii1-lpoii3 -- wt actual shares (PI for MPH) |
lpomii2 |
Num |
8 |
|
|
lpomii2: wt. avg. lpoii4-lpoii5 -- wt actual shares (PI for MAS) |
lpomii3 |
Num |
8 |
|
|
lpomii3: wt. avg. lpoii6-lpoii7 -- wt actual shares (PI for DEX) |
lpomii4 |
Num |
8 |
|
|
lpomii4: wt. avg. lpoii8-lpoii8 -- wt actual shares (PI for OTH) |
lpoii |
Num |
8 |
|
|
lpoii: wt. avg. lpomii1-lpoii4 -- wt actual shares (PI for ALL) |
lpzi1 |
Num |
8 |
|
|
lpzi1: wt. avg. lpz1-lpz3 -- wt fixed shares (PIz for MPH-IR) |
lpzi2 |
Num |
8 |
|
|
lpzi2: wt. avg. lpz4-lpz7 -- wt fixed shares (PIz for MPH-ER) |
lpzi3 |
Num |
8 |
|
|
lpzi3: wt. avg. lpz8-lpz8 -- wt fixed shares (PIz for MPH-OROS) |
lpzi4 |
Num |
8 |
|
|
lpzi4: wt. avg. lpz9-lpz10 -- wt fixed shares (PIz for MAS-IR) |
lpzi5 |
Num |
8 |
|
|
lpzi5: wt. avg. lpz11-lpz11 -- wt fixed shares (PIz for MAS-ER) |
lpzi6 |
Num |
8 |
|
|
lpzi6: wt. avg. lpz12-lpz14 -- wt fixed shares (PIz for DEX-IR) |
lpzi7 |
Num |
8 |
|
|
lpzi7: wt. avg. lpz15-lpz16 -- wt fixed shares (PIz for DEX-ER) |
lpzi8 |
Num |
8 |
|
|
lpzi8: wt. avg. lpz17(a,b,c,d) -- wt fixed shares (PIz for OTH) |
lpzmi1 |
Num |
8 |
|
|
lpzmi1: wt. avg. lpzi1-lpzi3 -- wt fixed shares (PIz for MPH) |
lpzmi2 |
Num |
8 |
|
|
lpzmi2: wt. avg. lpzi4-lpzi7 -- wt fixed shares (PIz for MAS) |
lpzmi3 |
Num |
8 |
|
|
lpzmi3: wt. avg. lpzi6-lpzi7 -- wt fixed shares (PIz for DEX) |
lpzmi4 |
Num |
8 |
|
|
lpzmi4: wt. avg. lpzi8-lpzi8 -- wt fixed shares (PIz for OTH) |
lpzi |
Num |
8 |
|
|
lpzi: wt. avg. lpzmii1-lpzii4 -- wt fixed shares (PIz for ALL) |
lpzii1 |
Num |
8 |
|
|
lpzii1: wt. avg. lpz1-lpz3 -- wt actual shares (PIz for MPH-IR) |
lpzii2 |
Num |
8 |
|
|
lpzii2: wt. avg. lpz4-lpz7 -- wt actual shares (PIz for MPH-ER) |
lpzii3 |
Num |
8 |
|
|
lpzii3: wt. avg. lpz8-lpz8 -- wt actual shares (PIz for MPH-OROS) |
lpzii4 |
Num |
8 |
|
|
lpzii4: wt. avg. lpz9-lpz10 -- wt actual shares (PIz for MAS-IR) |
lpzii5 |
Num |
8 |
|
|
lpzii5: wt. avg. lpz11-lpz11 -- wt actual shares (PIz for MAS-ER) |
lpzii6 |
Num |
8 |
|
|
lpzii6: wt. avg. lpz12-lpz14 -- wt actual shares (PIz for DEX-IR) |
lpzii7 |
Num |
8 |
|
|
lpzii7: wt. avg. lpz15-lpz16 -- wt actual shares (PIz for DEX-ER) |
lpzii8 |
Num |
8 |
|
|
lpzii8: wt. avg. lpz17(a,b,c,d) -- wt actual shares (PIz for OTH) |
lpzmii1 |
Num |
8 |
|
|
lpzmii1: wt. avg. lpzii1-lpzii3 -- wt actual shares (PIz for MPH) |
lpzmii2 |
Num |
8 |
|
|
lpzmii2: wt. avg. lpzii4-lpzii5 -- wt actual shares (PIz for MAS) |
lpzmii3 |
Num |
8 |
|
|
lpzmii3: wt. avg. lpzii6-lpzii7 -- wt actual shares (PIz for DEX) |
lpzmii4 |
Num |
8 |
|
|
lpzmii4: wt. avg. lpzii8-lpzii8 -- wt actual shares (PIz for OTH) |
lpzii |
Num |
8 |
|
|
lpzii: wt. avg. lpzmii1-lpzii4 -- wt actual shares (PIz for ALL) |
d1 |
Num |
8 |
|
|
|
d2 |
Num |
8 |
|
|
|
d3 |
Num |
8 |
|
|
|
d4 |
Num |
8 |
|
|
|
d5 |
Num |
8 |
|
|
|
d6 |
Num |
8 |
|
|
|
d7 |
Num |
8 |
|
|
|
d8 |
Num |
8 |
|
|
|
d9 |
Num |
8 |
|
|
|
d10 |
Num |
8 |
|
|
|
d11 |
Num |
8 |
|
|
|
d12 |
Num |
8 |
|
|
|
d13 |
Num |
8 |
|
|
|
d14 |
Num |
8 |
|
|
|
d15 |
Num |
8 |
|
|
|
d16 |
Num |
8 |
|
|
|
d17 |
Num |
8 |
|
|
|
d18 |
Num |
8 |
|
|
|
d19 |
Num |
8 |
|
|
|
d20 |
Num |
8 |
|
|
|
d21 |
Num |
8 |
|
|
|
d22 |
Num |
8 |
|
|
|
d23 |
Num |
8 |
|
|
|
d24 |
Num |
8 |
|
|
|
d25 |
Num |
8 |
|
|
|
d26 |
Num |
8 |
|
|
|
d27 |
Num |
8 |
|
|
|
d28 |
Num |
8 |
|
|
|
d29 |
Num |
8 |
|
|
|
d30 |
Num |
8 |
|
|
|
d31 |
Num |
8 |
|
|
|
d32 |
Num |
8 |
|
|
|
d33 |
Num |
8 |
|
|
|
d34 |
Num |
8 |
|
|
|
d35 |
Num |
8 |
|
|
|
d36 |
Num |
8 |
|
|
|
d37 |
Num |
8 |
|
|
|
d38 |
Num |
8 |
|
|
|
d39 |
Num |
8 |
|
|
|
d40 |
Num |
8 |
|
|
|
d41 |
Num |
8 |
|
|
|
d42 |
Num |
8 |
|
|
|
d43 |
Num |
8 |
|
|
|
d44 |
Num |
8 |
|
|
|
d45 |
Num |
8 |
|
|
|
d46 |
Num |
8 |
|
|
|
d47 |
Num |
8 |
|
|
|
d48 |
Num |
8 |
|
|
|
d49 |
Num |
8 |
|
|
|